Form 8-K - Current report:
SEC Accession No. 0001104659-17-015024
Filing Date
2017-03-08
Accepted
2017-03-08 06:04:07
Documents
5
Period of Report
2017-03-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-7834_18k.htm 8-K 22965
2 EX-99.1 a17-7834_1ex99d1.htm EX-99.1 10440
3 EX-99.2 a17-7834_1ex99d2.htm EX-99.2 13868
4 GRAPHIC g78341mmi001.gif GRAPHIC 3238
5 GRAPHIC g78341moi001.gif GRAPHIC 3399
  Complete submission text file 0001104659-17-015024.txt   57956
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 17673836
SIC: 2834 Pharmaceutical Preparations